Ken Macleod

Ken Macleod has held various roles throughout their work experience. Ken currently serves as a Director at Sequana Medical NV, JenaValve Technology, Inc., and Oxular. In 2021, they were a Partner at ROSETTA CAPITAL LIMITED. From 2016 to 2021, they held the position of Managing Director at Agate Strategic Advisors Ltd. Ken was a Director at Phase III Development Company SARL from 2009 to 2017. Ken Macleod served as Managing Partner at Visium Asset UK LLP; Visium Healthcare Partners Fund from 2013 to 2016. Ken was a Director at On-X Life Technologies, Inc from 2012 to 2016. Additionally, they served as a Partner at Paul Capital Advisors LLC and Chief Executive Officer at Paul Capital Advisors (UK) Ltd from 2004 to 2013.

Ken Macleod completed their Bachelor of Science degree in Biology at The University of Manchester from 1978 to 1981. Ken then pursued a Doctor of Philosophy degree in Biology at the University of York from 1981 to 1984. Prior to their studies at The University of Manchester, Ken Macleod also attended Aston University in 1978-1979, where they presumably studied Biology.